Monsanto's most recent trend suggests a bearish bias. One trading opportunity on Monsanto is a Bear Call Spread using a strike $125.00 short call and a strike $135.00 long call offers a potential 10.01% return on risk over the next 24 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $125.00 by expiration. The full premium credit of $0.91 would be kept by the premium seller. The risk of $9.09 would be incurred if the stock rose above the $135.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Monsanto is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Monsanto is bearish.
The RSI indicator is at 26.58 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Monsanto
Blog Exposure – European Commission Gives Conditional Approval for Bayer-Monsanto Deal
Fri, 23 Mar 2018 11:20:00 +0000
Stock Monitor: Arcadia Biosciences Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 23, 2018 / Active-Investors.com has just released a free research report on Monsanto Co. (NYSE: MON ). If you …
Understory Partners with Monsanto Company in Argentina to Inform Global Weather Impact on Agriculture Business
Thu, 22 Mar 2018 16:00:00 +0000
Understory, the weather network, edge computing, and machine learning company, today announced an international expansion and strategic collaboration with Monsanto , the global modern agriculture company.
Bayer-Monsanto Deal Now Awaits Approval from US and Russia
Thu, 22 Mar 2018 12:09:25 +0000
The Bayer-Monsanto (MON) deal is still under review for antitrust issues in the US due to concerns that the two companies combined could harm the competitive environment. Below, we’ll discuss some of the antitrust concerns in more detail. The above chart outlines some of the antitrust concerns that have pushed back merger approval deadlines. The list of concerns includes higher prices due to monopoly, a higher concentration that may lead to market dominance, challenges to R&D (research and development) and innovation, and limited choices to customers.
Bayer-Monsanto Deal Receives European Union Approval
Thu, 22 Mar 2018 12:09:24 +0000
On March 21, the year-long pending merger between agricultural (XLB) giants Monsanto (MON) and Bayer inched a step closer to closure. The companies received approval from the antitrust watchdogs in the EU (European Union). Following this news release, Monsanto closed about 57 basis points higher at $119, while Bayer rose by 15 basis points to 94.4 euros.
See what the IHS Markit Score report has to say about Monsanto Co.
Thu, 22 Mar 2018 12:00:57 +0000
This could indicate that investors who seek to profit from falling equity prices are not currently targeting MON. Over the last one-month, outflows of investor capital in ETFs holding MON totaled $1.57 billion.
Also on Market Tamer…
Follow Us on Facebook